CureVac Chief Technology Officer to Pursue New Career outside Biotech Industry
Dr. Mariola Fotin-Mleczek will resign from CureVac
18-Jan-2022 -
CureVac N.V. announced that the company’s Chief Technology Officer, Dr. Mariola Fotin-Mleczek, will resign from CureVac effective January 31, 2022. Mariola exits her role at CureVac after nearly 16 years of scientific leadership at the company, and 33 years in Germany, with plans to pursue a ...
CureVac
mRNA vaccines
personnel changes